OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
20
Results
Show all
Save search
Copy query
Show results for
Unknown
(20)
Release Date
2022
(5)
2023
(4)
2021
(4)
2024
(2)
2025
(1)
2019
(1)
2018
(1)
2017
(1)
2012
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections.
Not available
S-EPMC3422158
|
biostudies-literature
Cite
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.
Not available
S-EPMC8566220
|
biostudies-literature
Cite
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.
Not available
S-EPMC10597427
|
biostudies-literature
Cite
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC9941969
|
biostudies-literature
Cite
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC9857647
|
biostudies-literature
Cite
Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis.
Not available
S-EPMC9646734
|
biostudies-literature
Cite
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC9587497
|
biostudies-literature
Cite
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC10656670
|
biostudies-literature
Cite
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC11581631
|
biostudies-literature
Cite
Impact of postoperative acute kidney injury in patients undergoing major gastrointestinal surgery on 1-year survival and renal outcomes: a national multicentre cohort study.
Not available
S-EPMC8759520
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets